We are pleased to inform you that Agata Krawczyk-Balska was awarded the “Innovation Incubator 4.0” grant for preliminary research on the properties of a new antibacterial agent targeting the enzymes of pathogenic bacteria making them more susceptible to the immune system.

Title of the project: Peptidoglycan O-acetyltransferase inhibitor as a new antibiotic in the treatment of bacterial infections.